from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3923c/rnpA

LFCtreatmentdescriptionclass of inhibitor

1.773

Amikacinug/mL Amikacintranslation

2.140

Cap5-10ug/mL Capreomycintranslation

2.034

Rox10-50 ug/mL Roxithromycintranslation

0.643

SM2-5 ug/mL Streptomycintranslation

2.416

Tet5-10 ug/mL Tetracyclinetranslation

0.307

Rif0.2-5ug/mL Rifampicintranscription

-0.141

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.840

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.917

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.120

CPZ10-50 ug/mL Chlorpromazinerespiration

0.323

Clofazimine10-13 ug/mL Clofaziminerespiration

0.229

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.390

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-3.046

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.230

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.414

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.129

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.112

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-2.388

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.233

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-3.019

KCN5-20 ug/mL Potassium cyaniderespiration

-0.491

NaN30.2-2 mM Sodium aziderespiration

0.411

Nigericin50 uM Nigericinrespiration

-0.188

TRC10-150 ug/mL Triclosanrespiration

-0.606

TRZ10-25 ug/mL Thioridazinerespiration

0.397

Valinomycin0.5-10 uM Valinomycinrespiration

0.022

ZnSO42 mM ZnSO4respiration

0.376

menadione6-10 ug/mL Menadionerespiration

0.284

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.151

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.505

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.183

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.563

NRP_1Non-replicating persistence stage 1dosRassociated

0.321

Amp0.2mg/mL AmpicillincellWall

0.095

Cephalexin20-100 ug/mL CephalexincellWall

0.392

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.055

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.288

EMB10-20 ug/mL EthambutolcellWall

0.258

Eta12-40 ug/mL EthionamidecellWall

0.582

INH0.2-0.4 ug/mL IsoniazidcellWall

0.204

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.980

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.225

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.042

BZA0.12 mg/mL BenzamidearomaticAmides

-0.111

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.032

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.015

H2O24 mM hydrogen peroxideDNAdamaging

-0.288

Levo10 ug/mL LevofloxacinDNAdamaging

-0.311

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.266

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.285

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.489

UVUV-irradiationDNAdamaging

-0.309

ARP41-4 ug/mL Antitubercular compound ARP4?

0.066

Antimycin12.5-50 ug/mL Antimycin A?

0.066

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.070

PA_110-50 ug/mL Antitubercular compound PA-1?

0.136

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.465

PA8240.2-2 ug/mL PA-824?

-0.469

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.306

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.048

Verapamil50 uM Verapamil?

0.458

mercaptoethanol2 mM 2-Mercaptoethanol?

0.558

methoxatin10-20 ug/mL Methoxatin?